BGAI
TEVA icon

Bruce G. Allen Investments’s Teva Pharmaceuticals TEVA Stock Holding History

Bruce G. Allen Investments’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$20.4K Sell
601
-158
-21% -$5.26K 0.01% 410
2026
Q1 		$22.9K Buy
759
+2
+0.3% +$64 0.02% 383
2025
Q4 		$23.6K Buy
757
+32
+4% +$788 0.02% 375
2025
Q3 		$14.6K Buy
725
+125
+21% +$2.19K 0.01% 435
2025
Q2 		$10.1K Buy
600
+249
+71% +$4.02K 0.01% 477
2025
Q1 		$5.39K Sell
351
-167
-32% -$2.98K ﹤0.01% 558
2024
Q4 		$11.4K Buy
518
+43
+9% +$782 0.01% 455
2024
Q3 		$8.56K Buy
475
+57
+14% +$998 0.01% 500
2024
Q2 		$6.79K Buy
418
+62
+17% +$955 0.01% 524
2024
Q1 		$5.02K Hold
356
– – ﹤0.01% 586
2023
Q4 		$3.72K Buy
+356
New +$3.32K ﹤0.01% 634

Other funds holding TEVA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return

Bruce G. Allen Investments's TEVA Position: Q2 2026 in Review

Bruce G. Allen Investments reduced its Teva Pharmaceuticals (TEVA) stake by 21% in Q2 2026, selling an estimated $5.26K and leaving 601 shares worth $20.4K. The position accounts for 0.01% of the portfolio, ranked #410.

Bruce G. Allen Investments first reported a position in TEVA in Q4 2023 and has held it in 11 quarters since. The position peaked at $23.6K in Q4 2025. 672 funds tracked by Wall St. Rank hold TEVA as of Q2 2026.

  • Bruce G. Allen Investments held 601 shares of Teva Pharmaceuticals worth $20.4K as of Q2 2026.
  • Bruce G. Allen Investments sold 158 Teva Pharmaceuticals shares in Q2 2026, an estimated $5.26K.
  • Teva Pharmaceuticals made up 0.01% of Bruce G. Allen Investments's portfolio in Q2 2026, its #410 holding.
  • Bruce G. Allen Investments first reported a position in Teva Pharmaceuticals in Q4 2023 and has held it in 11 quarters since.
  • Bruce G. Allen Investments's Teva Pharmaceuticals position peaked at $23.6K in Q4 2025.
  • 672 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2026.

Based on Bruce G. Allen Investments's 13F filing for Q2 2026, filed 31 Jul 2026.